Variability and trends over time and across centres in haemodialysis weekly duration in Australia and New Zealand.
Adult
Aged
Ambulatory Care Facilities
/ trends
Australia
Female
Healthcare Disparities
/ trends
Hemodialysis, Home
/ trends
Humans
Incidence
Male
Middle Aged
Native Hawaiian or Other Pacific Islander
Nephrologists
/ trends
New Zealand
/ epidemiology
Practice Patterns, Physicians'
/ trends
Prevalence
Registries
Renal Dialysis
/ trends
Renal Insufficiency, Chronic
/ diagnosis
Time Factors
dialysis
dialysis duration
end-stage kidney disease
haemodialysis
treatment time
Journal
Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
09
06
2020
revised:
27
07
2020
accepted:
28
08
2020
pubmed:
24
10
2020
medline:
21
10
2021
entrez:
23
10
2020
Statut:
ppublish
Résumé
Haemodialysis treatment prescription varies widely internationally. This study explored patient- and centre-level characteristics associated with weekly haemodialysis hours. Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry data were analysed. Characteristics associated with weekly duration were evaluated using mixed-effects linear regression models with patient- and centre-level covariates as fixed effects, and dialysis centre and state as random effects using the 2017 prevalent in-centre haemodialysis (ICHD) and home haemodialysis (HHD) cohorts. Evaluation of patterns of weekly duration over time analysed the 2000 to 2017 incident ICHD and HHD cohorts. Overall, 12 494 ICHD and 1493 HHD prevalent patients in 2017 were included. Median weekly treatment duration was 13.5 (interquartile range [IQR] 12-15) hours for ICHD and 16 (IQR 15-20) hours for HHD. Male sex, younger age, higher body mass index, arteriovenous fistula/graft use, Aboriginal and Torres Strait Islander ethnicity and longer dialysis vintage were associated with longer weekly duration for both ICHD and HHD. No centre characteristics were associated with duration. Variability in duration across centres was very limited in ICHD compared with HHD, with variation in HHD being associated with state. Duration did not vary significantly over time for ICHD, whereas longer weekly HHD treatments were reported between 2006 and 2012 compared with before and after this period. This study in the Australian and New Zealand haemodialysis population showed that weekly duration was primarily associated with patient characteristics. No centre effect was demonstrated. Practice patterns seemed to differ across states/countries, with more variability in HHD than ICHD.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
153-163Subventions
Organisme : Centre Hospitalier de l'Université de Montréal and Fondation du CHUM
ID : Fellowship grant
Organisme : National Health and Medical Research Council
ID : Early Career Fellowship
Organisme : National Health and Medical Research Council
ID : Postgraduate Scholarship
Organisme : National Health and Medical Research Council
ID : Practitioner Fellowship
Organisme : Royal Australasian College of Physicians
ID : Jacquot Research Establishment Award
Organisme : Royal Australasian College of Physicians
ID : NHMCR Jacquot Award for Excellence
Informations de copyright
© 2020 Asian Pacific Society of Nephrology.
Références
Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981;305:1176-1181.
Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Mortality DLH. Duration of hemodialysis treatment. JAMA J Am Med Assoc. 1991;265:871-875.
Valderrabano F. Weekly duration of dialysis treatment - does it matter for survival? Nephrol Dial Transplant. 1996;11:569-572.
Shinzato T, Nakai S, Akiba T, et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant. 1997;12:884-888.
Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222-1228.
Marshall MR, Byrne BG, Kerr PG, McDonald SP. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int. 2006;69:1229-1236.
Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R. Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int. 2010;77:630-636.
Tentori F, Zhang J, Li Y, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2012;27:4180-4188.
Flythe JE, Curhan GC, Brunelli SM. Shorter length dialysis sessions are associated with increased mortality, independent of body weight. Kidney Int. 2012;83:104-113.
Swaminathan S, Mor V, Mehrotra R, Trivedi AN. Initial session duration and mortality among incident hemodialysis patients. Am J Kidney Dis. 2017;70:69-75.
Fotheringham J, Sajjad A, Stel VS, et al. The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis. Nephrol Dial Transplant. 2019;34:1577-1584.
Jansz TT, Noordzij M, Kramer A, et al. Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry. Nephrol Dial Transplant. 2020;35(3):488-495.https://doi.org/10.1093/ndt/gfz208.
Tattersall J, Martin-Malo A, Pedrini L, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant. 2007;22(SUPPL.2):ii5-ii21.
National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66:884-930.
Caring for Australians with Renal Impairment. The CARI Guidelines: Duration and frequency of haemodialysis therapy. http://www.cari.org.au/archived_guidelines.html. 2005. Accessed December 3, 2019.
Marshall MR, van der Schrieck N, Lilley D, et al. Independent community house hemodialysis as a novel dialysis setting: an observational cohort study. Am J Kidney Dis. 2013;61:598-607.
Urquhart-Secord R, Craig JC, Hemmelgarn B, et al. Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis. 2016;68:444-454.
Culleton B, Walsh M, Quinn R, Donnelly S, Friedrich M. Kumar a. effect of frequent nocturnal hemodialysis vs conventional hemodialysis. JAMA. 2007;298:1291-1299.
Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287-2300.
Rocco MV, Lockridge RS, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011;80:1080-1091.
Jardine MJ, Zuo L, Gray NA, et al. A trial of extending hemodialysis hours and quality of life. J Am Soc Nephrol. 2017;28:1898-1911.
Chertow GM, Levin NW, Beck GJ. Long-term effects of frequent in-center hemodialysis. J Am Soc Nephrol. 2016;27(6):1830-1836. https://doi.org/10.1681/ASN.2015040426.
Rocco M V, Daugirdas JT, Greene T. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis. 2015;66(3):459-468. https://doi.org/10.1053/j.ajkd.2015.02.331.
Suri RS, Larive B, Garg AX, et al. Burden on caregivers as perceived by hemodialysis patients in the frequent hemodialysis network (FHN) trials. Nephrol Dial Transplant. 2011;26:2316-2322.
Daugirdas JT, Greene T, Rocco MV, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83:949-958.